arrow
F

Filbert Francis

national institute for medical research
H指数:22
被引数:1,430

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Genomic profiling of drug resistance markers in Plasmodium falciparum samples from the Democratic Republic of the Congo (2017) and Tanzania (2020–2021)

刚果民主共和国(2017年)和坦桑尼亚(2020–2021年)恶性疟原虫样本中药物抗性标记物的基因组分析

2026-09-010
OAAI
Implementation and effectiveness of intermittent preventive treatment in school aged children using dihydroartemisinin-piperaquine to reduce malaria burden: an implementation research of a cluster randomised trial in Tanzania

使用双氢青蒿素哌喹间歇预防性治疗以降低疟疾负担:坦桑尼亚一项整群随机试验的实施研究——实施与有效性

2025-11-070
OAAI
Prevalence and risk factors associated with infections caused by Plasmodium parasites at micro-geographic level in three villages of Muheza district in Tanga region, north-eastern Tanzania

在坦桑尼亚东北部塔纳加地区穆赫扎区的三个村庄中,由Plasmodium寄生虫引起的感染的流行率及其相关风险因素在微地理层面的研究。

2025-10-010
OAAI
Temporal and spatial trends of the prevalence of infections caused by Plasmodium parasites among rural community members in three regions with varying transmission intensities in Mainland Tanzania

在坦桑尼亚大陆三个不同传播强度的地区,农村社区居民中由Plasmodium寄生虫引起的感染患病率的时空趋势。

2025-09-300
OAAI
Prevalence and drivers of malaria infection among asymptomatic and symptomatic community members in five regions with varying transmission intensity in mainland Tanzania
2025-01-241
OAAI
Evidence of artemisinin partial resistance in northwestern Tanzania: clinical and molecular markers of resistance
2024-11-016
OAAI
Efficacy and Safety of Artemether-Lumefantrine Against Uncomplicated Falciparum Malaria Infection in Tanzania, 2022: A Single-Arm Clinical Trial
2024-08-260
OA
Plasmodium falciparum pfhrp2 and pfhrp3 gene deletions among patients enrolled at 100 health facilities throughout Tanzania: February to July 2021
2024-04-088
OAAI
Malaria Species Positivity Rates Among Symptomatic Individuals Across Regions of Differing Transmission Intensities in Mainland Tanzania

坦桑尼亚大陆不同传播强度地区的有症状个体中的疟疾物种阳性率

2023-11-2210
OAAI